PharmaResearch Co., Ltd. - PE Ratio
214450.KQ
Price:
$400500
Market Cap:
$4.16T
PharmaResearch Co., Ltd., together with its subsidiaries, operates as a biopharmaceutical company primarily in South Korea. The company offers Re-An eye drops for protecting eyes from corneal damages with various causes; JBP PLAMON injection, a brown ampoule containing a pale yellow transparent liquid; ZADAXIN injection, an adjunctive therapy for influenza vaccination in immunocompromised elderly patients; PLACENTEX injection for the treatment and tissue restoration of wounds; CLEVIEL VOLUME to temporarily improve facial wrinkles in adults through the physical restoration; Rejuran HB plus which is used for temporary improvement of adult's crow's feet wrinkles; Rejuvenex injection, a tissue r...[Read more]
Industry
Medical - Pharmaceuticals
IPO Date
2015-07-24
Stock Exchange
KOE
Ticker
214450.KQ
PE Ratio
[27.34]
ROE
[26.52%]
Current Ratio
[7.72]
Dividend Yield
[0.27%]
Enterprise Value
[4.16T]
Dividend History
The PE Ratio as of August 2026 (TTM) for PharmaResearch Co., Ltd. (214450.KQ) is 27.34
According to PharmaResearch Co., Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is 27.34. This represents a change of 12.74% compared to the average of 24.25 of the last 4 quarters.
PharmaResearch Co., Ltd. (214450.KQ) Historical PE Ratio (quarterly & annually)
How has 214450.KQ PE Ratio performed in the past?
The mean historical PE Ratio of PharmaResearch Co., Ltd. over the last ten years is 23.51. The current 27.34 PE Ratio has changed 11.53% with respect to the historical average. Over the past ten years (40 quarters), 214450.KQ's PE Ratio was at its highest in in the December 2016 quarter at 116.68. The PE Ratio was at its lowest in in the December 2017 quarter at -192.54.
Average
23.51
Median
20.94
Minimum
14.61
Maximum
45.81
PharmaResearch Co., Ltd. (214450.KQ) PE Ratio by Quarter and Year
Discovering the peaks and valleys of PharmaResearch Co., Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 100.02%
Maximum Annual PE Ratio = 45.81
Minimum Annual Increase = -53.56%
Minimum Annual PE Ratio = 14.61
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | 25.36 | -13.22% |
| 2024 | 29.22 | 100.02% |
| 2023 | 14.61 | -14.99% |
| 2022 | 17.19 | -1.15% |
| 2021 | 17.39 | 4.78% |
| 2020 | 16.59 | -19.50% |
| 2019 | 20.61 | -3.11% |
| 2018 | 21.27 | -53.56% |
| 2017 | 45.81 | 69.18% |
| 2016 | 27.08 | -37.41% |
PharmaResearch Co., Ltd. (214450.KQ) Average PE Ratio
How has 214450.KQ PE Ratio performed in the past?
The current PE Ratio of PharmaResearch Co., Ltd. (214450.KQ) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
23.06
5-year avg
20.75
10-year avg
23.51
PharmaResearch Co., Ltd. (214450.KQ) PE Ratio vs. Peers
How is 214450.KQ’s PE Ratio compared to its peers?
PharmaResearch Co., Ltd.’s PE Ratio is greater than LigaChem Biosciences Inc. (-18.68), greater than HLB Co., Ltd. (-23.93), greater than Peptron, Inc. (-202.35), greater than Kolon TissueGene, Inc. (-9.47), greater than SK bioscience Co.,Ltd. (-34.23), greater than SK Biopharmaceuticals Co., Ltd. (16.93), greater than Hugel, Inc. (18.32), greater than Voronoi, Inc. (-37.33), greater than D&D Pharmatech (-105.82), greater than OliX Pharmaceuticals,Inc (-162.64),
| Company | PE Ratio | Market cap |
|---|---|---|
| -18.68 | $3.64T | |
| -23.93 | $5.14T | |
| -202.35 | $4.15T | |
| -9.47 | $1.76T | |
| -34.23 | $2.86T | |
| 16.93 | $6.55T | |
| 18.32 | $2.65T | |
| -37.33 | $2.79T | |
| -105.82 | $2.33T | |
| -162.64 | $1.99T |
Build a custom stock screener for PharmaResearch Co., Ltd. (214450.KQ) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like PharmaResearch Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
PharmaResearch Co., Ltd. (214450.KQ) and other stocks custom spreadsheet templates
The easiest way to analyze a company like PharmaResearch Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the PE Ratio?
How can you use the PE Ratio?
What is PharmaResearch Co., Ltd.'s PE Ratio?
How is the PE Ratio calculated for PharmaResearch Co., Ltd. (214450.KQ)?
What is the highest PE Ratio for PharmaResearch Co., Ltd. (214450.KQ)?
What is the 3-year average PE Ratio for PharmaResearch Co., Ltd. (214450.KQ)?
What is the 5-year average PE Ratio for PharmaResearch Co., Ltd. (214450.KQ)?
How does the current PE Ratio for PharmaResearch Co., Ltd. (214450.KQ) compare to its historical average?